Somewhat Favorable Press Coverage Somewhat Unlikely to Impact USANA Health Sciences (USNA) Stock Price

News coverage about USANA Health Sciences (NYSE:USNA) has trended somewhat positive recently, according to Accern. The research firm rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. USANA Health Sciences earned a news impact score of 0.18 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.9362646957785 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the news headlines that may have effected Accern Sentiment’s scoring:

USANA Health Sciences (NYSE:USNA) traded up 0.71% on Tuesday, reaching $64.00. 78,890 shares of the company’s stock traded hands. The firm’s 50-day moving average is $64.34 and its 200 day moving average is $60.91. The firm has a market cap of $1.57 billion, a PE ratio of 16.16 and a beta of 1.13. USANA Health Sciences has a 12 month low of $52.55 and a 12 month high of $75.00.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, May 2nd. The company reported $0.91 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by $0.01. The company had revenue of $255.32 million for the quarter. USANA Health Sciences had a net margin of 9.71% and a return on equity of 31.84%. Equities analysts predict that USANA Health Sciences will post $3.95 EPS for the current year.

USNA has been the topic of several recent research reports. Zacks Investment Research upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Wednesday, April 12th. Pivotal Research reiterated a “hold” rating and set a $55.00 target price (down from $75.00) on shares of USANA Health Sciences in a research report on Monday, May 1st. Finally, BidaskClub upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research report on Tuesday, June 13th.

ILLEGAL ACTIVITY WARNING: This piece was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://sportsperspectives.com/2017/07/18/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-usana-health-sciences-usna-stock-price.html.

In related news, Director Myron W. Wentz sold 40,000 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $64.99, for a total value of $2,599,600.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gilbert A. Fuller sold 4,884 shares of the firm’s stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $64.38, for a total value of $314,431.92. Following the completion of the sale, the director now directly owns 4,884 shares of the company’s stock, valued at approximately $314,431.92. The disclosure for this sale can be found here. Insiders sold 134,735 shares of company stock valued at $8,371,021 in the last ninety days. 53.20% of the stock is currently owned by insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply